Fucoidan attenuates chronic colitis and behavioral deficits by reshaping gut microbiota-brain axis balance
Inflammatory bowel disease (IBD) often coexists with depression, posing considerable challenges for treatment. This study aimed to investigate the therapeutic potential of fucoidan, a compound derived from Laminaria japonica, in a dextran sulfate sodium (DSS)-induced model of IBD with comorbid depre...
Príomhchruthaitheoirí: | Zi-Wei Ye, Zhong-Yu Yuan, Jun Wang, Hua Li, Cheng-Fu Li, Guang-Hui Xu, Li-Tao Yi, Wei-Feng Huang |
---|---|
Formáid: | Alt |
Teanga: | English |
Foilsithe / Cruthaithe: |
Elsevier
2024-01-01
|
Sraith: | Journal of Functional Foods |
Ábhair: | |
Rochtain ar líne: | http://www.sciencedirect.com/science/article/pii/S1756464623005510 |
Míreanna comhchosúla
Míreanna comhchosúla
-
Recent insights of fucoidan probiotic and its effect on gut microbiota
de réir: Bassma H. Elwakil, et al.
Foilsithe / Cruthaithe: (2023-06-01) -
Fucoidan: Structure and Bioactivity
de réir: Ruixiang Zhao, et al.
Foilsithe / Cruthaithe: (2008-08-01) -
Effects of IRW and IQW on Oxidative Stress and Gut Microbiota in Dextran Sodium Sulfate-Induced Colitis
de réir: Gang Liu, et al.
Foilsithe / Cruthaithe: (2018-11-01) -
Neuroprotective effect of fucoidan by regulating gut-microbiota-brain axis in alcohol withdrawal mice
de réir: Meilan Xue, et al.
Foilsithe / Cruthaithe: (2021-11-01) -
Research Progress on Fucoidan-Degrading Enzymes
de réir: WEI Zhen, CHEN Jinling, YANG Jie
Foilsithe / Cruthaithe: (2024-05-01)